Get started
Author

Ahmet Burak Ağaoğlu

Observed names: AHMET BURAK AGAOGLU, Ahmet B. Ağaoğlu, Ahmet Burak Agaoglu, Ahmet Burak AĞAOĞLU
ORCID: 0000-0001-5528-7852
Observed ORCID: 0000-0001-5528-7852
OpenAlex ID: A5038048149
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma
2024 · Haci Arak, Suna Erkiliç, et al. · Journal of Immunotherapy · 9
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
2024 · İsmail Beypınar, Hacer Demir, et al. · Breast Cancer Research and Treatment · 5
Intestinal Anti-Inflammatory and Anti-Oxidant Activity of The Aqueous Extract From Arum Dioscoridis in Acetic Acid Induced Colitis in Rats
2022 · Ahmet Burak AĞAOĞLU, Kadir GİŞİ, et al. · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · 4
PDF
Prognostic value of the HALP score in patients with testicular cancer: a retrospective study
2025 · Ahmet Burak Agaoglu, Atike Pınar Erdogan, et al. · Clinical & Translational Oncology · 3
PDF
IPI score as a new prognostic index in extensive stage small cell lung cancer
2025 · Ahmet Burak Ağaoğlu, Ferhat Ekinci, et al. · PeerJ · 2
PDF
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer
2025 · Ahmet Burak Agaoglu, Atike Pinar Erdogan, et al. · Medicina · 2
PDF
Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
2025 · Gökhan Şahin, Esmanur Kaplan Tüzün, et al. · International Journal of Cancer · 2
Prognostic value of the CHAM score in non-small cell lung cancer patients treated with nivolumab
2026 · Ahmet Burak Agaoglu, Ferhat Ekinci, et al. · Clinical & Translational Oncology · 1
Postoperative CA-125 as a Prognostic Marker for Overall Survival in Ovarian Cancer
2025 · Ahmet Burak Agaoglu, Ferhat Ekinci, et al. · Journal of College of Physicians And Surgeons Pakistan · 1
PDF
Clinicopathological Perspectives of Liver Mass Biopsies: A Single Center Experience of 406 Cases
2025 · Ömer Atmış, Hanife Seda Mavili, et al. · Archives of Iranian Medicine · 1
PDF
Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II–III colon cancer
2026 · Ahmet Burak Ağaoğlu, Ferhat Ekinci, et al. · Cancer Chemotherapy and Pharmacology
Autophagy- and Stress-Related Biomarkers in Pretreatment Rectal Adenocarcinoma Biopsies: Associations With Pathologic Response to Neoadjuvant Therapy and Survival
2026 · Ömer Atmiş, Selin Yurtsever Inan, et al. · Applied immunohistochemistry & molecular morphology
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study
2026 · Suheda Atas Ipek, Sendag Yaslikaya, et al. · Journal of Clinical Medicine
PDF
Thiamine deficiency in oncology: Clinical insights from two cases of Wernicke’s encephalopathy
2026 · AHMET BURAK AGAOGLU, FERHAT EKINCI, et al. · The National Medical Journal of India
PDF
Survival Benefit of Temozolomide Plus Irinotecan as Second-Line Therapy in Small Cell Lung Cancer: A Retrospective Single-Center Study
2025 · Omer Acar, Ahmet Burak Agaoglu, et al. · Journal of Clinical Medicine
PDF
Convulsion due to Ertapenem in a Renal Transplant Patient
2019 · Egemen Şenel, Fatma Betül Güzel, et al. · Turkish Journal of Nephrology
Böbrek Nakli Hastasında Ertapenem Kullanımına Bağlı Gelişen Konvülsiyon: Olgu Sunumu
2018 · Egemen Şenel, Fatma Betül Güzel, et al. · Turkish Journal of Nephrology
Meme Karsinomlarında Klinik, Histopatolojik ve Prognostik Parametreler ile Östrojen ve Progesteron Reseptör Boyanma Özelliklerinin Karşılaştırılması
2002 · Cengiz Doğan, Hayreddin Yekeler, et al. · Fırat Tıp Dergisi
Works count: 18
Citation count: 30
H-index: 3
I10-index:
Year
Topic
Type